Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria

被引:149
作者
Djimdé, AA
Doumbo, OK
Traore, O
Guindo, AB
Kayentao, K
Diourte, Y
Niare-Doumbo, S
Coulibaly, D
Kone, AK
Cissoko, Y
Tekete, M
Fofana, B
Dicko, A
Diallo, DA
Wellems, TE
Kwiatkowski, D
Plowe, CV
机构
[1] Univ Maryland, Sch Med, Ctr Vaccine Dev, Malaria Sect, Columbia, MD 21044 USA
[2] Univ Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bandiagara Malaria Project, Bamako, Mali
[3] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[4] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[5] Univ Bamako, Fac Med Pharm & Dent, Dept Hematol, Bamako, Mali
关键词
D O I
10.4269/ajtmh.2003.69.558
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Residents of malaria-endemic areas sometimes spontaneously clear Plasmodium falciparum infection without drug treatment, implying an important role for host factors such as immunity in this clearance. Host factors may also contribute to clearance of parasites resistant to a treatment drug. Chloroquine resistance is caused by point mutations in P. falciparum chloroquine resistance transporter (pfcrt) gene. We investigated the clearance of malaria parasites carrying the key chloroquine resistance-conferring PfCRT mutation K76T in patients treated with chloroquine. We found that the ability to clear these resistant parasites is strongly dependent on age (the best surrogate for protective immunity in endemic areas), suggesting that host immunity plays a critical role in the clearance of resistant P. falciparum infections. Age-adjusted comparison of subjects able to clear resistant parasites and those unable to do so provides a new phenotype for identifying host immune and genetic factors responsible for protective immunity against malaria.
引用
收藏
页码:558 / 563
页数:6
相关论文
共 39 条
[31]   Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali:: Parasitologic resistance versus therapeutic efficacy [J].
Plowe, CV ;
Doumbo, OK ;
Djimde, A ;
Kayentao, K ;
Diourte, Y ;
Doumbo, SN ;
Coulibaly, D ;
Thera, M ;
Wellems, TE ;
Diallo, DA .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 64 (5-6) :242-246
[32]   Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum [J].
Reed, MB ;
Saliba, KJ ;
Caruana, SR ;
Kirk, K ;
Cowman, AF .
NATURE, 2000, 403 (6772) :906-909
[33]   Do maternally acquired antibodies protect infants from malaria infection? [J].
Riley, EM ;
Wagner, GE ;
Akanmori, BD ;
Koram, KA .
PARASITE IMMUNOLOGY, 2001, 23 (02) :51-59
[34]   The effect of chloroquine on the production of interferon-γ, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice [J].
Rosa, R ;
Silveira, H ;
Seixas, E ;
Rolao, N ;
Santos-Gomes, G ;
do Rosário, V .
JOURNAL OF PARASITOLOGY, 1999, 85 (05) :956-960
[35]   Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism [J].
Shear, HL ;
Grinberg, L ;
Gilman, J ;
Fabry, ME ;
Stamatoyannopoulos, G ;
Goldberg, DE ;
Nagel, RL .
BLOOD, 1998, 92 (07) :2520-2526
[36]  
Smith T, 1999, T ROY SOC TROP MED H, V93, pS59
[37]   Risk of severe malaria among African infants: Direct evidence of clinical protection during early infancy [J].
Snow, RW ;
Nahlen, B ;
Palmer, A ;
Donnelly, CA ;
Gupta, S ;
Marsh, K .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :819-822
[38]   Chloroquine-resistant malaria [J].
Wellems, TE ;
Plowe, CV .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) :770-776
[39]  
1996, ASSESSMENT THERAPEUT